This content is machine translated Ginkgo biloba extract in the Alzheimer's mouse model Effects on disease-associated microglia subpopulations During the progression of Alzheimer’s disease, microglial cells located in the vicinity of plaques become overactivated and release cytotoxic mediators such as TNFα. In an animal study published in 2025,...…
View Post 4 min This content is machine translated Epilepsy Cannabidiol for refractory epilepsy syndromes The pharmaceutical formulation of high-purity cannabidiol is approved for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex. Despite many years of clinical experience, there...…
View Post 3 min This content is machine translated Multiple sclerosis Spirulina as adjuvant therapy? Reduction of cytokines and inflammation Disease-modifying therapies reduce relapse rates in multiple sclerosis. However, they often only incompletely address the aspects of oxidative stress and long-term neurodegeneration. Spirulina, a microalgae, is known for its strong...…
View Post 4 min This content is machine translated Pelargonium sidoides Scoping review sheds light on the multifaceted spectrum of effects The widely recognized medicinal plant Pelargonium sidoides belongs to the cranesbill family (Geraniaceae) and is also known as Cape geranium. A review published last December summarizes the diverse therapeutic effects...…
View Post 2 min This content is machine translated Chronic pain Nano-ECS modulator Adezunap improves therapy success Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new...…
View Post 6 min This content is machine translated Lavender oil preparation: long-term use and use in adolescents New database analysis closes important knowledge gaps Volz et al. conducted a retrospective analysis to find out more about the use of a proprietary lavender oil preparation over a longer period of time (>3 or >6 months)...…
View Post 6 min This content is machine translated Cannabis - medical vs. non-medical use Interim assessment: the boundaries are fluid Although it has been possible to obtain a prescription for cannabis medicines in Switzerland for a number of years, it is not uncommon for patients to incur considerably higher costs...…
View Post 6 min This content is machine translated Ginkgo biloba for mild dementia: new meta-analysis Improvements in several domains relevant to everyday life There is a need for effective and well-tolerated treatments that can be used in the early stages of dementia. Overall, the evidence suggests that taking a standardized, proprietary ginkgo extract...…
View Post 5 min This content is machine translated Long-term study with dementia patients Ginkgo biloba extract significantly reduces the risk of progression In a retrospective cohort study with a follow-up period of up to 10 years, dementia patients who were prescribed a Ginkgo biloba extract showed a significantly lower risk of progression...…
View Post 10 min This content is machine translated Benign prostatic hyperplasia Phytotherapeutic alternatives to established therapies Benign prostatic syndrome (BPH) is one of the most common diagnoses in urological practice and is associated with a variety of lower urinary tract symptoms ( LUTS), which can severely...…
View Post 6 min This content is machine translated Evidence, potential and limits Phytotherapy for rheumatoid arthritis Herbal medicines open up new perspectives in the concomitant and alternative treatment of rheumatoid arthritis (RA). In view of the limited efficacy and side effects of many standard drugs, phytopharmaceuticals...…
